Yoğun Bakım Ünitesinde Ventriküler Taşikardilere Yaklaşım

Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2022; 43(40): 3997-4126. doi:10.1093/eurheartj/ehac262
Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018; 72(14): e91-e220. doi:10.1016/j.jacc.2017.10.054
Senaratne JM, Sandhu R, Barnett CF, et al. Approach to ventricular arrhythmias in the intensive care unit. J Intensive Care Med. 2021;36(7), 731-748.
Steinberg JS et al. New-onset sustained ventricular tachycardia after cardiac surgery. Circulation. 1999;99(7):903–8.
Valderrábano RJ, Blanco A, Santiago-Rodriguez EJ, et al. Risk factors and clinical outcomes of arrhythmias in the medical intensive care unit. J intensive care. 2016;4(1), 1-10.
Brugada P, Brugada J, Mont L, Smeets J, Andries EW. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 1991;83:1649 –1659.
Vereckei A, Duray G, Szénási G, Altemose GT, Miller JM. Application of a new algorithm in the differential diagnosis of wide QRS complex tachycardia. Eur Heart J. 2007 Mar;28 (5):589-600.
Willems JL, Robles de Medina EO, Bernard R, Coumel P, Fisch C, Krikler D, Mazur NA, Meijler FL, Mogensen L, Moret P, Pisa Z, Rautaharju PM, Surawicz B, Watanabe Y, Wellens HJJ. Criteria for intraventricular conduction disturbances and pre-excitation. J Am Coll Cardiol 1985;5:1261–1275.
Vereckei A. Current algorithms for the diagnosis of wide QRS complex tachycardias. Curr cardiol rev. 2014;10,3:262-276.
Hong J, Xu M. Propofol terminates ventricular fibrillation storm caused by pulmonary embolism. Chin Med J (Engl). 2014; 127: 3840.
Topaloğlu S, Aras D, Özeke Ö. Arrhythmic electrical storm: an important problem in patients with an implantable cardioverter defibrillator. Turk Kardiyol Dern Ars. 2006; 34(2): 126-130.
Vaseghi M, Shivkumar K. The role of the autonomic nervous system in sudden cardiac death. Prog Cardiovasc Dis 2008; 50: 404–419.
Greene M, Newman D, Geist M, et al. Is electrical storm in ICD patients the sign of a dying heart?: outcome of patients with clusters of ventricular tachyarrhythmias. Europace. 2000;2: 263–69.
Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM. Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 2000;102:742-7.
Sesselberg HW, Moss AJ, McNitt S, et al. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm 2007; 4: 1395–1402.
Chatzidou S, Kontogiannis C, Tsilimigras DI, et al. Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator. J Am Coll Cardiol. 2018; 71(2):1897-1906.
Chew HC, & Lim SH. Verapamil for ventricular tachycardia. Ame J Emerg Med. 2007;25(5), 572-575.
Desai AD, Chun S, Sung RJ. The role of intravenous amiodarone in the management of cardiac arrhythmias. Ann Intern Med. 1997; 127(2):294-303.
Van der Ree MH, Van Dussen L, Rosenberg N, et al. Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review. Europace, 2022;24(11), 1809-1823.
Apte N, & Kalra DK. Pharmacotherapy in ventricular arrhythmias. Cardiology, 2023;148(2), 119-130.
Curnis A, Salghetti F, Cerini M, et al. Ranolazine therapy in drug-refractory ventricular ar- rhythmias. J Cardiovasc Med. 2017;18(7): 534–8.
Lei M, Wu L, Terrar DA, Huang CL. Modernized classification of cardiac antiarrhythmic drugs. Circulation. 2018;138(4): 1879-1896.
Tzivoni D, Keren A, Cohen AM, et al. Magnesium therapy for torsades de pointes. Am J Cardiol. 1984;53(2):528-530.

Schupp T, Bertsch T, von Zworowsky M, et al. Prognostic impact of potassium levels in patients with ventricular tachyarrhythmias. Clinl Res Cardiol. 2020;109:1292-1306.
Salama A, Abdullah A, Wahab A, et al. Is obstructive sleep apnea associated with ventricular tachycardia? A retrospective study from the National Inpatient Sample and a literature review on the pathogenesis of Obstructive Sleep Apnea. Clinical cardiology, 2018;41(12):1543-47.
Huang K, Bennett RG, Campbell T, et al. Early Catheter Ablation Versus Initial Medical Therapy for Ventricular Tachycardia Storm. Circulation: Arrhythmia and Electrophysiology, 2022;15(12): e011129.